Literature DB >> 15122974

Influence of immobilization stress on the levels of CaMKII and phospho-CaMKII in the rat hippocampus.

Takami Suenaga1, Shigeru Morinobu, Ki-Ichiro Kawano, Takuya Sawada, Shigeto Yamawaki.   

Abstract

The phosphorylation of calcium/calmodulin-dependent protein kinase (CaMK) II, induced by an increase in the intracellular Ca2+ concentration, is involved in the alteration of brain functions such as memory formation. In the present study, we examined the influence of various immobilization stress paradigms on the phosphorylation of CaMKII (phospho-CaMKII) and CaMKII levels in the rat hippocampus. Immunoblot and immunohistochemical analyses were performed to examine the levels of CaMKII and phospho-CaMKII. Real-time quantitative polymerase chain reaction (PCR) was performed to analyse the mRNA levels of N-methyl-D-aspartic acid (NMDA) and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subtypes. Acute (single) and repeated (4 d), but not chronic (14 d), stress exposure of 45 min or longer duration significantly increased phospho-CaMKII levels without affecting the levels of CaMKII. Pre-treatment with NBQX, a selective AMPA receptor antagonist, significantly prevented this stress-induced increase. In contrast, two NMDA receptor antagonists, LY235959 and MK-801, showed no inhibitory effect on phospho-CaMKII levels during acute stress. Neither acute nor chronic stress changed mRNA levels of NMDA and AMPA receptors. These results demonstrate that immobilization stress promotes the phosphorylation of CaMKII. The increase in the intracellular Ca2+ concentration by the activation of AMPA receptors may play a role in the stress-induced phospho-CaMKII in the rat hippocampus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15122974     DOI: 10.1017/S1461145704004304

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  16 in total

1.  Pharmacogenetics in mood disorder.

Authors:  Charles U Nnadi; Joseph F Goldberg; Anil K Malhotra
Journal:  Curr Opin Psychiatry       Date:  2005-01       Impact factor: 4.741

2.  βCaMKII in lateral habenula mediates core symptoms of depression.

Authors:  Kun Li; Tao Zhou; Lujian Liao; Zhongfei Yang; Catherine Wong; Fritz Henn; Roberto Malinow; John R Yates; Hailan Hu
Journal:  Science       Date:  2013-08-30       Impact factor: 47.728

3.  Modification of hippocampal markers of synaptic plasticity by memantine in animal models of acute and repeated restraint stress: implications for memory and behavior.

Authors:  Shaimaa Nasr Amin; Ahmed Amro El-Aidi; Mohamed Mostafa Ali; Yasser Mahmoud Attia; Laila Ahmed Rashed
Journal:  Neuromolecular Med       Date:  2015-02-14       Impact factor: 3.843

4.  Vorinostat ameliorates impaired fear extinction possibly via the hippocampal NMDA-CaMKII pathway in an animal model of posttraumatic stress disorder.

Authors:  Yasutaka Matsumoto; Shigeru Morinobu; Shigeto Yamamoto; Tomoya Matsumoto; Shiro Takei; Yosuke Fujita; Shigeto Yamawaki
Journal:  Psychopharmacology (Berl)       Date:  2013-04-13       Impact factor: 4.530

Review 5.  Neuronal correlates of depression.

Authors:  Dipesh Chaudhury; He Liu; Ming-Hu Han
Journal:  Cell Mol Life Sci       Date:  2015-11-05       Impact factor: 9.261

6.  Alpha-Ca2+/calmodulin-dependent protein kinase II contributes to the developmental programming of anxiety in serotonin receptor 1A knock-out mice.

Authors:  Luisa Lo Iacono; Cornelius Gross
Journal:  J Neurosci       Date:  2008-06-11       Impact factor: 6.167

Review 7.  The Calcium/Calmodulin-Dependent Kinases II and IV as Therapeutic Targets in Neurodegenerative and Neuropsychiatric Disorders.

Authors:  Kinga Sałaciak; Aleksandra Koszałka; Elżbieta Żmudzka; Karolina Pytka
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

8.  Regulation of AMPA receptor surface trafficking and synaptic plasticity by a cognitive enhancer and antidepressant molecule.

Authors:  H Zhang; L-A Etherington; A-S Hafner; D Belelli; F Coussen; P Delagrange; F Chaouloff; M Spedding; J J Lambert; D Choquet; L Groc
Journal:  Mol Psychiatry       Date:  2012-06-26       Impact factor: 15.992

9.  Possible inhibitor from traditional Chinese medicine for the β form of calcium-dependent protein kinase type II in the treatment of major depressive disorder.

Authors:  Tzu-Chieh Hung; Wen-Yuan Lee; Kuen-Bao Chen; Hung-Jin Huang; Yueh-Chiu Chan; Cheng-Chun Lee; Calvin Yu-Chian Chen
Journal:  Biomed Res Int       Date:  2014-06-18       Impact factor: 3.411

Review 10.  The temporal dynamics model of emotional memory processing: a synthesis on the neurobiological basis of stress-induced amnesia, flashbulb and traumatic memories, and the Yerkes-Dodson law.

Authors:  David M Diamond; Adam M Campbell; Collin R Park; Joshua Halonen; Phillip R Zoladz
Journal:  Neural Plast       Date:  2007       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.